Clinical Trials Browser

Phase 2 × Lymphangioleiomyomatosis × 90 days × Clear all

NCT03304678 2026-02-18

Discovery of Sirolimus Sensitive Biomarkers in Blood

Phase 2 Completed

33 enrolled 6 charts

Lymphangioleiomyomatosis